Anatomical and functional recurrence after dexamethasone intravitreal implants: A 6-month prospective study

Eye (Basingstoke)

Volumn 29, Issue 6, 2015, Pages 769-775

  Fortoul, V ^a   Denis, P ^a   Kodjikian, L ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ANATOMICAL CONCEPTS; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVAL HEMORRHAGE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOREIGN BODY REACTION; FUNCTIONAL ASSESSMENT; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; INTRAVITREAL IMPLANT; MALE; QUALITATIVE ANALYSIS; RETINA MACULA CYSTOID EDEMA; RETINA VEIN OCCLUSION; RETINAL THICKNESS; VISUAL ACUITY; COMPLICATION; DRUG IMPLANT; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINA; RETINAL VEIN OCCLUSION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETINA; RETINAL VEIN OCCLUSION; VISUAL ACUITY;

EID: 84930840965     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2015.36     Document Type: Article

References (17)

1. Noma H, Mimura T, Tatsugawa M, Shimada K. Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series. BMC Ophthalmol 2013; 13: 78.
2. Yao J, Chen Z, Yang Q, Liu X, Chen X, Zhuang M et al. Proteomic analysis of aqueous humor from patients with branch retinal vein occlusion-induced macular edema. Int J Mol Med 2013; 32(6): 1421-1434.
3. Noma H, Mimura T, Shimada K. Role of inflammation in previously untreated macular edema with branch retinal vein occlusion. BMC Ophthalmol 2014; 14(1): 67.
4. Noma H, Mimura T, Yasuda K, Shimura M. Role of soluble vascular endothelial growth factor receptors-1 and-2, their ligands, and other factors in branch retinal vein occlusion with macular edema. Invest Ophthalmol Vis Sci 2014; 55(6): 3878-3885.
5. Glacet-Bernard A, Coscas G, Zourdani A, Soubrane G, Souied EH. Steroids and macular edema from retinal vein occlusion. Eur J Ophthalmol 2011; 21(Suppl 6): S37-S44.
6. Pielen A, Feltgen N, Isserstedt C, Callizo J, Junker B, Schmucker C. Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review. PLoS One 2013; 8(10): e78538.
7. Haller JA, Bandello F, Belfort R, Blumenkranz MS, Gillies M, Heier J et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011; 118(12): 2453-2460.
8. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117(6): 1102-1112 e1.
9. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME et al. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology 2011; 118(2): 345-352.
10. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117(6): 1124-1133 e1.
11. Yeh W-S, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012; 119(6): 1190-1198.
12. Mayer WJ, Wolf A, Kernt M, Kook D, Kampik A, Ulbig M et al. Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion. Eye (Lond) 2013; 27(7): 816-822.
13. Merkoudis N, Granstam E. Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting. Eur J Ophthalmol 2013; 23(4): 558-563.
14. Matonti F, Meyer F, Guigou S, Barthelemy T, Dumas S, Gobert F et al. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice. Acta Ophthalmol 2013; 91(7): e584-e586.
15. Bezatis A, Spital G, Höhn F, Maier M, Clemens CR, Wachtlin J et al. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up-the SOLO study. Acta Ophthalmol 2013; 91(5): e340-e347.
16. Capone A, Singer MA, Dodwell DG, Dreyer RF, Oh KT, Roth DB et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study). Retina 2014; 34(2): 342-351.
17. Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G et al. Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2014; 24(1): 1-9.